At present predictive biomarkers to identify underlying resistance mechanisms and guide effective post-AI therapy for individual patients are missing

Management of Aromatase Inhibitor-Resistant Disease with Estrogen, Selective Estrogen Receptor Down-Regulators, and Other Agents / Oakman C; Santarpia L; Moretti E; Biganzoli L; Di Leo A. - In: CURRENT BREAST CANCER REPORTS. - ISSN 1943-4596. - ELETTRONICO. - (2011), pp. 24-33.

Management of Aromatase Inhibitor-Resistant Disease with Estrogen, Selective Estrogen Receptor Down-Regulators, and Other Agents

MORETTI, ERICA;
2011

Abstract

At present predictive biomarkers to identify underlying resistance mechanisms and guide effective post-AI therapy for individual patients are missing
2011
24
33
Oakman C; Santarpia L; Moretti E; Biganzoli L; Di Leo A
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/957843
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact